Those results promise to prevent the hyperglycemia caused by insufficient insulin secretion developed in type 2 diabetes in obese people or change the natural course of an already developed disease by reducing glucose levels caused by insufficient insulin production over time. This evidence concerns the gene INS and type 2 diabetes mellitus.